REATA PHARMACEUTICALS
Live / Registered — Registered (as of 18 Oct 2022)
What this means for you
Registered since 18 Oct 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90706652
- Registration number
- 6875316
- Mark type
- Design + words
- Filed
- 12 May 2021
- Published for opposition
- 02 Aug 2022
- Registered
- 18 Oct 2022
- Attorney of record
- Andrea K. Shannon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and for use in oncology, ophthalmology, and the prevention and treatment of gastrointestinal diseases, diseases and disorders of the immune system including autoimmune diseases, skin diseases, and kidney diseases
Owner
- Reata Pharmaceuticals, Inc., Plano, TX, US
- Reata Pharmaceuticals, Inc., Plano, TX, US
- Reata Pharmaceuticals, Inc., Plano, TX, US
Prior registrations
Prosecution history
- 24 May 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 18 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 02 Aug 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Aug 2022 — PUBLISHED FOR OPPOSITION
- 13 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 26 Jan 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Jan 2022 — NON-FINAL ACTION E-MAILED
- 26 Jan 2022 — NON-FINAL ACTION WRITTEN
- 19 Jan 2022 — ASSIGNED TO EXAMINER
- 12 Aug 2021 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 11 Aug 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 May 2021 — NEW APPLICATION ENTERED